Compare Illumina, Inc. (ILMN) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Motorola Solutions Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $28.96B), while Motorola Solutions Inc trades at $466.86 (market cap $76.45B). The key difference: Motorola Solutions Inc is far larger — about 2.6× Illumina, Inc.'s market cap, and Motorola Solutions Inc pays a 1.05% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | MSI | |
|---|---|---|
Market Cap | $28.96B | $76.45B |
Sector | Health | Technology |
52-Week High | $205.10 | $490.30 |
52-Week Low | $91.00 | $363.83 |
Enterprise Value | $30.32B | $85.36B |
Dividend Yield | — | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $187.96, down 2.97% on the day, but maintains strong fundamental momentum with three consecutive quarterly earnings beats. The stock shows robust profitability with 66.38% gross margins and 18.34% net income margins, though technical indicators suggest near-term bearish pressure. Recent institutional buying activity and positive analyst coverage (51% buy ratings) support the stock's long-term growth narrative in the genomics sector.
The outlook remains positive with a consensus price target of $201.58 representing 7% upside potential. Key catalysts include continued NovaSeq X adoption and AI partnerships, while risks involve competitive pressures and execution challenges in achieving projected revenue growth. The company's turnaround from net losses to $850M profit in 2025 demonstrates improved operational efficiency.
Motorola Solutions (MSI) trades at $467.55, down 1.38% on the day, yet maintains a strong bullish technical trend with moving averages signaling buy. The company reported robust Q2 2026 results, beating EPS estimates with $4.41 versus $3.85 expected, and raised full-year guidance amid record backlog of $15.6 billion. Revenue grew 13% year-over-year, driven by demand in public safety communications and software services. Valuation ratios remain elevated, with a P/E of 36.84 and P/S of 6.42, reflecting premium pricing for its growth trajectory.
Outlook is positive with analyst consensus price target of $533.80 implying 14% upside, supported by strong fundamentals and institutional accumulation. Key risks include execution challenges to meet raised guidance, high valuation sensitivity to earnings misses, and macroeconomic pressures on public sector spending. The stock's current level near pivot point resistance at $471 requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
